Prognostic value of Thyroid Transcription Factor-1 expression in lung adenocarcinoma in patients treated with anti PD-1/PD-L1

Anti-PD1/PD-L1-directed immune checkpoint inhibitors are game changers in advanced non-small-cell lung cancer, but biomarkers are lacking. The aim of our study was to find clinically relevant biomarkers of the efficacy of ICI in non-squamous NSCLC. We conducted a retrospective study of patients rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Galland, Loïck, Le Page, Anne Laure, Lecuelle, Julie, Bibeau, Frederic, Oulkhouir, Youssef, Derangère, Valentin, Truntzer, Caroline, Ghiringhelli, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331027/
https://www.ncbi.nlm.nih.gov/pubmed/34377595
http://dx.doi.org/10.1080/2162402X.2021.1957603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331027/
https://www.ncbi.nlm.nih.gov/pubmed/34377595
http://dx.doi.org/10.1080/2162402X.2021.1957603

Ejemplares similares